article thumbnail

Fewer New Drugs but Affordable Access for Existing Ones: The Big Elephant in the Room

Policy Prescription

Within the context of the global pandemic and a coming battle in Congress about the high cost of prescription drugs, Patients for Affordable Drugs founder David Mitchell tactfully presents the roadmap of Covid vaccine development to prevent people from buying into Big Pharma’s scare tactic. 3) were implemented.

Drugs 52
article thumbnail

Sanofi successfully priced an inaugural sustainability-linked bond indexed on access to medicines

The Pharma Data

650 million fixed rate notes, due April 2029, bearing interest at an annual rate of 1.250%. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog: Biosimilars

covered insulin product or vaccine). Each phase-in policy allows eligible manufacturers to build up in a stepwise manner to the 10% and 20% applicable discounts by 2029 and 2031, respectively. state pharmaceutical assistance programs). had Part D expenditures on or before August 16, 2022).

article thumbnail

What is the largest CRO in the US?

Vial

billion by 2029. Existing lab services include bioanalytical, biomarker , and vaccine sciences labs in Virginia; a GMP lab in Ireland; central labs and biomarker operations in Belgium, Kentucky, and Singapore; and bioanalytical, biomarker, vaccine sciences, and central labs in China. from 2024 to reach US$129.8

article thumbnail

Making a “Miracle” HIV Medicine

Codon

million new HIV infections by 2029, undermining progress toward the UN’s goal. A lifelong HIV vaccine would be ideal, but developing one has proved difficult. In 2009, a public-private partnership called the Gavi Alliance used an AMC to spur the development of pneumonia vaccines. By February, the U.S.